NGMedical Completes Enrollment in MOVE-C Clinical Trial
The multicenter one- and two-level trial is designed to support a future Premarket Approval application for MOVE-C....
The multicenter one- and two-level trial is designed to support a future Premarket Approval application for MOVE-C....
Designed with or without integrated fixation and options to gain up to 30 degrees of angulation, the implant can be...
The milestone represents advancement for the LinQ Sacroiliac Joint Stabilization System....
The company's OneLIF interbody spinal fusion system was used for the first time outside the U.S., in the Panamanian market....
This milestone translates to more than 3,700 implants placed, demonstrating rapid adoption since commercial launch in 2023....
aprevo devices leverage AI-driven surgical planning software and digital production to create the personalized spine fusion devices....
Spineart’s Ti-LIFE microporous technology is applied across a range of posterior, lateral and cervical cages....
Nevro1 is an FDA 510(k)-cleared device intended to transfix the SI joint for immediate stability and long-term fusion. ...
With these positive coverage updates, it is estimated that one-level lumbar TDR coverage is nearly 95% of the commercially-covered lives...
Vertiwedge is the first intraosseous device designed to facilitate and maintain vertebral body correction of partially collapsed vertebrae....
As a guest member you get access to more articles and videos every month.
We’ll send a recovery link to your email.
Return to Homepage